Access cutting-edge follicular lymphoma treatment through this clinical trial at a research site in Ann Arbor. Study-provided care at no cost to qualified participants.
Access follicular lymphoma specialists in Ann Arbor at no cost
This study follows strict safety protocols and ethical guidelines
All study-related follicular lymphoma treatment provided free
This study will evaluate the safety, efficacy, pharmacokinetics, and immunogenicity of mosunetuzumab (Mosun) + lenalidomide (Len) (Mosun + Len) in participants with follicular lymphoma (FL). This study will also compare the pharmacokinetics, pharmacodynamics, safety, efficacy, and immunogenicity of IV mosunetuzumab + len vs subcutaneous (SC) mosunetuzumab + len.
Sponsor: Hoffmann-La Roche
Check if you qualify for this follicular lymphoma clinical trial in Ann Arbor, MI
If you're searching for follicular lymphoma treatment options in Ann Arbor, MI, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Ann Arbor research site is actively enrolling participants for this clinical trial. You'll receive care from experienced follicular lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.